The UK Coronavirus Job Retention Scheme and smoking, alcohol consumption and vaping during the COVID-19 pandemic: evidence from eight longitudinal population surveys.


Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
21 09 2022
Historique:
received: 07 02 2022
accepted: 02 08 2022
entrez: 20 9 2022
pubmed: 21 9 2022
medline: 24 9 2022
Statut: epublish

Résumé

Employment disruptions can impact smoking and alcohol consumption. During the COVID-19 pandemic, many countries implemented furlough schemes to prevent job loss. We examine how furlough was associated with smoking, vaping and alcohol consumption in the UK. Data from 27,841 participants in eight UK adult longitudinal surveys were analysed. Participants self-reported employment status and current smoking, current vaping and alcohol consumption (>4 days/week or 5+ drinks per typical occasion) both before and during the early stages of the pandemic (April-July 2020). Risk ratios were estimated within each study using modified Poisson regression, adjusting for a range of potential confounders, including pre-pandemic behaviour. Findings were synthesised using random effects meta-analysis. Compared to stable employment and after adjustment for pre-pandemic characteristics, furlough was not associated with smoking (ARR = 1.05; 95% CI: 0.95-1.16; I We found no clear evidence of furlough or unemployment having adverse impacts on smoking, vaping or drinking behaviours during the early stages of the COVID-19 pandemic in the UK. Differences in risk compared to those who remained employed were largely explained by pre-pandemic characteristics.

Sections du résumé

BACKGROUND
Employment disruptions can impact smoking and alcohol consumption. During the COVID-19 pandemic, many countries implemented furlough schemes to prevent job loss. We examine how furlough was associated with smoking, vaping and alcohol consumption in the UK.
METHODS
Data from 27,841 participants in eight UK adult longitudinal surveys were analysed. Participants self-reported employment status and current smoking, current vaping and alcohol consumption (>4 days/week or 5+ drinks per typical occasion) both before and during the early stages of the pandemic (April-July 2020). Risk ratios were estimated within each study using modified Poisson regression, adjusting for a range of potential confounders, including pre-pandemic behaviour. Findings were synthesised using random effects meta-analysis.
RESULTS
Compared to stable employment and after adjustment for pre-pandemic characteristics, furlough was not associated with smoking (ARR = 1.05; 95% CI: 0.95-1.16; I
CONCLUSIONS
We found no clear evidence of furlough or unemployment having adverse impacts on smoking, vaping or drinking behaviours during the early stages of the COVID-19 pandemic in the UK. Differences in risk compared to those who remained employed were largely explained by pre-pandemic characteristics.

Identifiants

pubmed: 36127702
doi: 10.1186/s12916-022-02511-0
pii: 10.1186/s12916-022-02511-0
pmc: PMC9489267
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

345

Subventions

Organisme : Chief Scientist Office
ID : SCAF/15/02
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_20059
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_20030
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU17
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/2
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

J Behav Med. 2007 Jun;30(3):263-85
pubmed: 17514418
BMC Med Genet. 2006 Oct 02;7:74
pubmed: 17014726
Am J Public Health. 1984 Jul;74(7):660-6
pubmed: 6611092
Drug Alcohol Rev. 2021 Sep;40(6):890-899
pubmed: 33657644
Cochrane Database Syst Rev. 2014;(12):CD010216
pubmed: 25515689
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
J Public Health Med. 2001 Dec;23(4):306-11
pubmed: 11873893
Addiction. 2022 Mar;117(3):772-783
pubmed: 34431577
Ind Relat (Berkeley). 2013 Apr;52(2):444-466
pubmed: 23543880
JAMA. 2010 Mar 24;303(12):1159-66
pubmed: 20332401
Addiction. 2016 Aug;111(8):1457-65
pubmed: 27162105
Int J Environ Res Public Health. 2021 May 28;18(11):
pubmed: 34071475
J Health Soc Behav. 1992 Dec;33(4):328-47
pubmed: 1464718
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Stat Methods Med Res. 2016 Oct;25(5):1925-1937
pubmed: 24108272
Eur J Public Health. 2005 Jun;15(3):262-9
pubmed: 15755781
Int J Epidemiol. 2006 Feb;35(1):34-41
pubmed: 16155052
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
J Epidemiol Community Health. 2021 Mar;75(3):224-231
pubmed: 32978210
Addiction. 2005 Sep;100(9):1330-9
pubmed: 16128722
Addiction. 2020 Feb;115(2):230-238
pubmed: 31560404
J Epidemiol Community Health. 2006 Dec;60(12):1077-9
pubmed: 17108305
Alcohol Clin Exp Res. 2011 Dec;35(12):2101-12
pubmed: 21919918
BMJ. 2016 Apr 27;352:i1981
pubmed: 27121591
Soc Sci Med. 1991;32(9):989-1005
pubmed: 2047903
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Int J Epidemiol. 2006 Aug;35(4):836-43
pubmed: 16931528
BMJ. 2020 Apr 27;369:m1557
pubmed: 32341002
Ann Behav Med. 2014 Apr;47(2):148-57
pubmed: 24072618
Addiction. 2021 Oct;116(10):2825-2836
pubmed: 33751671
PLoS One. 2021 Mar 4;16(3):e0247959
pubmed: 33662014
J Epidemiol Community Health. 2021 Dec;75(12):1136-1142
pubmed: 34039660
J Epidemiol Community Health. 2020 Sep;74(9):683-688
pubmed: 32503892
J Epidemiol Community Health. 2020 Sep;74(9):681-682
pubmed: 32669357
J Clin Epidemiol. 2021 Aug;136:44-54
pubmed: 33652080

Auteurs

Michael J Green (MJ)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK. michael.green@glasgow.ac.uk.

Jane Maddock (J)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.

Giorgio Di Gessa (G)

Institute of Epidemiology and Health Care, University College London, London, UK.

Bożena Wielgoszewska (B)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Sam Parsons (S)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Gareth J Griffith (GJ)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Jazz Croft (J)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Anna J Stevenson (AJ)

Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.

Charlotte F Huggins (CF)

Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.

Charlotte Booth (C)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Jacques Wels (J)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.

Richard J Silverwood (RJ)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Praveetha Patalay (P)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.
Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Alun D Hughes (AD)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.

Nishi Chaturvedi (N)

MRC Unit for Lifelong Health and Ageing, University College London, London, UK.

Laura D Howe (LD)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.

Emla Fitzsimons (E)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Srinivasa Vittal Katikireddi (SV)

MRC/CSO Social & Public Health Sciences Unit, University of Glasgow, Glasgow, UK.

George B Ploubidis (GB)

Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH